Clinical Trial Update: Study of Eszopiclone Compared to Placebo on Daytime Function in Subjects With Insomnia Related to Rheumatoid Arthritis [Phase 3]

View source ↗

Summary

A Phase 3 trial compared eszopiclone with placebo to assess daytime function in adults with insomnia related to rheumatoid arthritis; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insomnia
• Rheumatoid Arthritis

Drugs mentioned

• Lunesta (eszopiclone)

Snippet

Sponsor: Sumitomo Pharma America, Inc. | Conditions: Insomnia, Arthritis, Rheumatoid | Phase 3 | Status: COMPLETED